Craig Davenport, Chief Executive Officer of Endocare, Inc., Rings the NASDAQ Closing Bell.
March 13, 2008 - Endocare, Inc. [ENDO]
About this Marketsite Event:
Craig Davenport, Chief Executive Officer of Endocare, Inc.(ENDO), presides over the Closing bell in celebration of the companies listing with the Nasdaq OMX Group.
Endocare, Inc. -- www.endocare.com -- is an innovative medical device company focused on the development of minimally invasive technologies for tissue and tumor ablation. Endocare has initially concentrated on developing technologies for the treatment of prostate cancer and believes that its proprietary technologies have broad applications across a number of markets, including the ablation of tumors in the kidney, lung and liver and palliative intervention (treatment of pain associated with metastases).
Additional information is available at www.endocare.com.
Press Inquiries Only:
Organizations interested in obtaining NASDAQ-listed company bell ringing ceremony photographs for press purposes, must first receive approval from the listed company before requesting photographs from NASDAQ. Please provide the company contact information from whom you received approval to Jolene Libretto at
jolene.libretto@nasdaq.com. Kindly credit © 2008, The Nasdaq Stock Market, Inc. Reprinted with permission.
Other Photography Inquiries:
For all other photography inquiries, please contact NASDAQ’s photographer, Rob Tannenbaum at
rob.tannenbaum@nasdaq.com.
© 2008, The NASDAQ OMX Group, Inc. Reprinted with permission.
